Related Experiment Videos
Mesenteric ischaemia in haemodialysis patients: a case/control study
Nader Bassilios1, Victorio Menoyo, Anne Berger
1CHPVR, AURA, Réseau Nephropar, Hopital Necker, 149 rue de Sèvres, F-75743 Paris Cedex 15, France. nbassilios@hotmail.com
Summary
Mesenteric ischaemia in dialysis patients requires prompt diagnosis and treatment. While risk factors remain unclear, early intervention leads to a favorable prognosis, similar to patients without this condition.
Area of Science:
- Nephrology
- Gastroenterology
- Vascular Surgery
Background:
- Mesenteric ischaemia is an increasing concern in dialysis patients, with unclear risk factors and prognosis.
- This study addresses the need for better understanding of mesenteric ischaemia in this population.
Purpose of the Study:
- To describe clinical, biological, and radiological aspects of mesenteric ischaemia in haemodialysis patients.
- To identify risk factors for mesenteric ischaemia in haemodialysis patients.
- To evaluate the prognosis of haemodialysis patients following mesenteric ischaemia.
Main Methods:
- A case-control study involving 15 haemodialysis patients with mesenteric ischaemia and 30 matched controls.
- Data collected included clinical presentation, laboratory results, radiological findings, and treatment outcomes.
- Survival analysis was performed to compare case and control groups.
Main Results:
- Hypotensive episodes during dialysis preceded mesenteric ischaemia in 47% of cases.
- Common symptoms included abdominal pain, guarding, fever, and hyperleucocytosis (87%).
- The caecum was the most frequently affected segment (47%); 12 patients underwent surgery.
- No significant differences in cardiovascular risk factors or haemodialysis characteristics were found between cases and controls.
- Median survival for cases was 600 days, significantly lower than controls (P=0.0132).
- Patients surviving >3 months had a median survival of 1500 days, similar to controls.
Conclusions:
- Mesenteric ischaemia should be suspected in dialysis patients with abdominal pain during or after dialysis.
- Prompt diagnosis and treatment are crucial for a favourable prognosis.
- Survival outcomes can be similar to matched controls if patients survive the initial 3 months post-ischaemia.